Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huolisu Oral Solution in depression after PCI with hormone-axis and TCM syndrome correlation assessment
ChiCTR2300070121Phase 4Completed
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jul 2019
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Huolisu in major depressive disorder (MDD), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Patient Health Questionnaire-9. Started Jul 2019; status: completed.
02
Drugs
Huolisu
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2300070121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070121.